NWPF

News ArchivesRead News

OHSU Breakthrough makes Time's Top 10 List

Friday December 06, 2013

Elizabeth Hayes

Portland Business Journal - Oregon Health & Science University made the Time Magazine Top 10 list of medical breakthroughs of 2013, with a discovery that could accelerate treatments for Parkinson’s disease, multiple sclerosis, cardiac disease and spinal injuries.

OHSU isn’t named by name, but it was the university's breakthrough that is referenced here: “Scientists are now convinced that the most common neurodegenerative diseases, like Alzheimer’s and Parkinson’s, might be better treated if it were possible to identify patients early in their disease and intervene with treatments.”

By the time the first symptoms of Parkinson’s appear, damage to the brain is well underway, Time noted. Proteins in the spinal fluid may help identify patients in the first stages of the disease.

We wrote about the breakthrough when it was announced back in May. The university said at the time that its researchers were able to reprogram human skill cells and make them embryonic stem cells that can transform into other cell types.

The research was led by Shoukhrat Mitalipov, a senior scientist at OHSU’s Oregon National Primate Research Center.

Other discoveries on the Time list included new genes linked to Alzheimer’s, hair transplants, the dosage level for the HPV vaccine and a better pregnancy test.

Hayes, E. (6 Dec. 2013). Portland Business Journal. OHSU breakthrough makes Time's Top 10 list. www.bizjournals.com.

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement